Our finding that hepcidin inhibits transforming growth factor β1 (TGFβ1)-mediated Smad3 phosphorylation by degrading FPN that is upregulated and responsible for the suppression of Akt signalling in activated HSCs, offers the novel therapeutic approaches to overcome liver fibrosis. The gene discussed is SMAD3; the disease is Hepatic fibrosis.